Background/Aims: The senescence marker protein-30 (SMP30) is a 34 kDa protein originally identified in rat liver that shows decreased levels with age. Several functional studies using SMP30 knockout (Smp30 Y/2 ) mice established that SMP30 functions as an antioxidant and protects against apoptosis. To address the potential role of SMP30 in nonalcoholic fatty liver disease (NAFLD) pathogenesis, we established Smp30 Y/2 mice on a Lepr db/db background (Lepr db/db Smp30 Y/2 mice).
Introduction
Metabolic syndrome has been described as the association of insulin resistance, hypertension, hyperlipidemia and obesity. Its prevalence has increased dramatically, mainly in developed countries. The hepatic manifestations of metabolic syndrome include nonalcoholic fatty liver disease (NAFLD) and its progressive variant, nonalcoholic steatohepatitis (NASH) [1, 2] . Several animal models have been proposed for NAFLD and NASH research [3] . Since leptin plays a major role in food intake and energy expenditure, total leptin deficiency or leptin resistance can lead to massive obesity, type 2 diabetes, dyslipidemia and fatty liver. Therefore, many investigations pertaining to NAFLD/ NASH have been carried out in genetic leptin-deficient ob/ob mice or leptin-resistant db/db mice that were fed a high fat diet (HFD) or the methionine/choline deficiency diet [3] [4] [5] . However, these models differ significantly from the human NAFLD/NASH phenotype in a number of pathogenically important ways.
The senescence marker protein-30 (SMP30) is a 34 kDa protein that was originally identified in rat liver and its levels decrease with age [6] . We previously reported that SMP30 participates in Ca 2+ efflux by activating the calmodulin-dependent Ca 2+ -pump that confers resistance to cell injury caused by high intracellular Ca 2+ concentrations [7] . We identified SMP30 as a gluconolactonase (GNL) that is involved in L-ascorbic acid biosynthesis in mammals, and have established SMP30-knockout (KO) mice [8] . The livers of SMP30-KO mice are highly susceptible to tumor necrosis factor-a (TNF-a) and Fas-mediated apoptosis, indicating that SMP30 has an anti-apoptotic effect [9] . SMP30-KO mice showed mitochondrial damage and abnormal accumulation of triglycerides, cholesterol, and phospholipids in the liver [10] . In addition, we reported that decreased SMP30 levels contribute to lowered glucose tolerance [11] . These results are in agreement with several functional studies, which also established that SMP30 functions as an antioxidant and anti-apoptotic protein [12] [13] [14] [15] .
To address the potential role of SMP30 in NAFLD/NASH pathogenesis, we generated SMP30- KO 
Materials and Methods

Animal crossing and genotyping, and experimental protocol
We used type 2 diabetic obese Lepr db/db mice with a C57BLKS/J background. Male Lepr db/+ mice were obtained from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). SMP30-knockout (KO) mice with a C57BL/6 background were established and maintained as described previously [8, 9] . Heterozygous SMP30-KO male mice do not exist, because the Smp30 gene is located on the X chromosome. SMP30-KO mice cannot synthesize vitamin C in vivo, because in mammals SMP30 is the penultimate enzyme in the vitamin C biosynthetic pathway [8] . To maintain vitamin C levels in tissues that were similar to that of wild type mice, and to eliminate any possible confounding influences of vitamin C deficiency, these mice were given free access to water supplemented with 1.5 g/L vitamin C and 10 mM ethylenediaminetetraacetic acid (EDTA) to avoid the effects of vitamin C deficiency [16] . As schematically illustrated in Figure 1A, 
Blood and liver tissue collection
All mice were fasted for 16 h and anesthetized at the age of 24 weeks. Blood was obtained from the inferior vena cava, anticoagulated with EDTA, and subsequently centrifuged at 8806g for 15 min at 4uC. Mice were systemically perfused with ice-cold phosphate buffered saline through the hepatic portal vein to wash out remaining blood cells and then the livers were removed. The whole body subcutaneous fat was collected and the weight measured. The livers were immersed in RNAlaterH (Life Technologies Corp., Carlsbad, CA, USA) for RNA extraction and fixed with 10% neutral buffered formalin for histological analysis or frozen in liquid nitrogen for biochemical analysis. All samples were stored at 280uC until use.
Biochemical analysis of blood
Blood glucose levels were measured using a glucometer (Glutest Every; Sanwa Kagaku Kenkyusho Co., Ltd., Aichi, Japan). Plasma insulin levels were measured using an enzyme-linked immunoassay system (Ultra sensitive mouse insulin ELISA kit; Morinaga Institute of Biological Science Inc., Kanagawa, Japan). Plasma total cholesterol (T-cho), triglyceride (TG), phospholipid (PL), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels were measured by enzymatic assay kits (Wako Pure Chemicals Industries, Osaka, Japan).
Western blotting analysis
Livers were homogenized in ice-cold homogenization buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1 mM phenyl methanesulfonyl fluoride, and a protease inhibitor cocktail (cOmplete, EDTA-free; Roche Diagnostics GmbH, Mannheim, Germany)) for 30 seconds using a high speed homogenizer (POLYTRONH PT-MR 2100; Kinematica AG, Switzerland). The homogenate was then centrifuged at 21,0006g for 10 min at 4uC. The supernatants were boiled for 5 min with a lysis buffer containing 0.125 M Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.2% bromophenol blue at a ratio of 1:1. Total protein equivalents for each sample were separated on a 14% polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. The membrane was incubated with the primary antibody, followed by incubation with a horseradish peroxidase-linked goat anti-rabbit IgG (Bio-Rad Laboratories, Tokyo, Japan). The primary antibodies used were: anti-rat SMP30 rabbit polyclonal antibody (Cosmo Bio Co., Ltd., Tokyo, Japan), anti-phosphorylated eukaryotic initiation factor-2a (p-eIF2a) rabbit monoclonal antibody (#3597, Cell Signaling Technology, Beverly, MA) and anti-C/EBP homologous protein (CHOP) rabbit polyclonal antibody (sc-575, Santa Cruz Biotechnology, Santa Cruz, CA) and b-actin (Cell Signaling Technology, Beverly, MA) as a loading control. After washing, immunoreactivity was detected using ECL chemiluminescence reagents (ECL plus, GE Healthcare Japan, Tokyo, Japan). Chemiluminescence signals were quantified with a LAS-3000 imaging system (Fujifilm, Tokyo, Japan). The mean signals from five Lepr db/+ Smp30 Y/+ mice were assigned a relative value of 1.0. The total protein concentration was determined with a PierceH BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Waltham, MA) using bovine serum albumin as a standard.
Measurement of vitamin C levels in the liver
Livers were homogenized in 14 vol 5.4% metaphosphate and 1 mM EDTA, and the homogenate was then centrifuged at 21,0006g for 15 min at 4uC. Vitamin C was analyzed by highperformance liquid chromatography (HPLC) using an Atlantis dC18 5 mm column (4.66150 mm; Nihon Waters, Tokyo, Japan) [17] . The mobile phase was 50 mM phosphate buffer (pH 2.8), 0.2 g/L EDTA, and 2% methanol at a flow rate of 1.3 ml/min, and electrical signals were recorded using an electrochemical detector equipped with a glassy carbon electrode at +0.6 V.
Measurement of T-cho, TG and PL in the liver
Liver tissues were homogenized with 2 vol. of water using a handy homogenizer (Moji-mojikun; Nippon Genetics, Tokyo, Japan). Homogenates were added to a chloroform-methanol (2:1; v/v) mixture, and centrifuged at 21,0006g for 10 min at 4uC. The supernatant organic phase was then collected, dried under nitrogen gas and resolubilized in 2-propanol. T-cho, TG and PL concentrations in total lipid extracts were determined using commercial enzymatic kits (Wako Pure Chemical Industries, Osaka, Japan).
Thiobarbituric acid reactive substances (TBARS) assay
Lipid peroxidation was estimated by the amounts of TBARS in the liver that were determined according to the method of Ohkawa et al. [18] . The livers were first homogenized in ice-cold 0.1 M phosphate buffer (pH 7.4). The homogenates were then centrifuged at 15,0006g for 30 min at 4uC and the supernatant was used for further assays. One volume of sample was mixed thoroughly with two volumes of stock solution (15% (w/v) trichloroacetic acid, 0.375% (w/v) thiobarbituric acid, and 0.25 mM HCl). The mixture was then heated for 30 min in a boiling water bath. After cooling, the flocculate precipitate was removed by centrifugation at 1,0006g for 10 min and the absorbance (OD 532 nm) of the sample was measured. The TBARS levels are expressed as the equivalent amounts of malondialdehyde produced from 1,1,3,3-tetramethoxypropane.
HPLC analysis of plasma lipoproteins
Plasma lipoproteins were analyzed using a HPLC service (LipoSEARCH) at Skylight Biotech Inc. (Akita, Japan), as previously described [19] . In brief, 10 mL of whole plasma was injected into two connected columns (30067.8 mm) packed with TSKgel LipopropakXL (Tosoh, Tokyo, Japan) and lipoproteins were separated with 0.05 mol/L Tris-buffered acetate (pH 8.0) containing 0.3 mol/L sodium acetate, 0.05% sodium azide, and 
Histological and immunohistochemical examination of liver
To evaluate histological changes, fixed liver sections were subjected to hematoxylin-eosin (H&E) staining or immunohistochemical staining with an anti-4-hydroxy-2-nonenal (4-HNE) protein adducts monoclonal antibody (1:40 dilution; Nikken SEIL, Shizuoka, Japan).
The H&E-stained specimens were anonymized, and five different areas per mouse were randomly selected by a researcher. These specimens were scored by two independent investigators blinded to sample identity according to the NASH activity score (NAS) [20] for the degree of steatosis (0-3), lobular inflammation (0-3) and hepatocellular ballooning (0-2). The average of the two investigators' scores was regarded as the score for each mouse.
4-HNE was detected by indirect immunoperoxidase staining using corresponding Histofine Simple Stain MAX-PO kits (Nichirei Biosciences, Tokyo, Japan) and 3, 3-diaminobenzidine (DAB) as a chromogenic substrate. After DAB staining, nuclei were counterstained with Mayer's hematoxylin. Two independent observers evaluated the intensity of 4-HNE immunostaining and assigned scores of 0, 1, 2, or 3 (negative (including faint staining), weak, moderate, or strong, respectively).
RNA isolation, first-strand cDNA synthesis, and gene expression analysis
Liver tissue was finely ground with a liquid nitrogen-cooled mortar and pestle and homogenized in ice-cold TRIzol reagent (Life Technologies, Carlsbad, CA, USA) before isolation of total RNA according to the manufacturer's instructions. Total RNA (0.5 mg) was reverse-transcribed using PrimeScript RT Master Mix (TaKaRa Bio Inc., Shiga, Japan) for first-strand cDNA synthesis with an oligonucleotide dT primer and random hexamer priming according to the manufacturer's recommendations.
The mRNA expression levels of the following proteins: acetylCoA carboxylase (ACC), fatty acid synthase (FAS), sterol regulatory element-binding protein 1c (SREBP1c), SREBP2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCoAR), peroxisome proliferator-activated receptor-a (PPARa), medium-chain acyl-CoA dehydrogenase (MCAD), microsomal triglyceride transfer protein (MTP), apolipoprotein-B100 (ApoB100), LDL receptor (LDLR) and VLDL receptor (VLDLR), CD36 and spliced X-box binding protein 1 (sXBP1), all of which are involved in lipid and lipoprotein metabolism, were quantitated using real-time reverse transcription polymerase chain reaction (RT-PCR). RT-PCR was performed using a Thermal Cycler Dice Real Time System II (TaKaRa Bio Inc.) and real-time SYBRH Premix Ex Taq TM (TaKaRa Bio Inc.) according to the manufacturer's instructions. The specific primers for the target genes and b-actin are described in Table 1 . The following PCR conditions were used: 1 cycle for 30 s at 95uC, followed by 40 cycles for 5 s at 95uC, and 30 s at 60uC. The product specificity generated for each primer set was examined for each fragment using a melting curve and gel electrophoresis. The relative expression levels of each targeted gene were normalized to b-actin threshold cycle (CT) values and quantified using the comparative threshold cycle 2 2DDCT method as previously described [21] . Signals from Lepr db/+ Smp30 Y/+ mice were assigned a relative value of 1.0. Five mice from each group were examined, and real time RT-PCR was run in duplicate for each sample.
Statistical analysis
Data are expressed as means 6 SEM. Statistical differences between groups were determined by one-way analysis of variance (ANOVA) with Scheffe's post hoc test. A P value,0.05 was considered to be statistically significant.
Results
Generation of
As shown in Fig. 1A (Fig. 1C ). There were no significant differences found in the liver vitamin C concentration among any of the experimental groups (Fig. 1D ).
Given Fig. 3A . Either with or without Smp30, the levels of VLDL-(Fr. 3-7), LDL-(Fr. 8-11), very-small particle size LDL-(Fr. 12-13) and HDL-cho (Fr. [14] [15] [16] [17] [18] [19] [20] (Fig. 3B-F ). There were no significant differences in VLDL-cho levels in Lepr db/db
Smp30
Y/2 and Lepr db/db Smp30 Y/+ mice (Fig. 3B) . Although there were no significant differences in LDLcho (Fr. [8] [9] [10] [11] (Fig. 3C) , the very-small sized LDL-cho particles of Fr.12 and Fr.13 that correspond to small dense LDL-cho (sdLDL-cho) in (Fig. 3F ). 
Increased hepatic lipid (TG, T-cho and PL) and lipid peroxidation (TBARS) levels in
Smp30
Y/2 mice (P,0.001), and were significantly lower than in Lepr db/db Smp30 Y/+ mice (P,0.05). CD36 mRNA levels were 
Discussion
The two-hit theory proposed by Day and James [22] , in which the initial trigger is the hepatic accumulation of excessive fat, followed by the second hit of oxidative stress, is widely advocated as a pathogenic mechanism for NASH. Therefore, it is of great interest to study in greater detail the role of SMP30 in relation to the pathogenic mechanism for NAFLD/NASH in SMP30-KO mice on a Lepr db/db background. [23] , lipopolysaccharide (LPS) [24] or D-galactosamine/LPS [25] . Furthermore, we recently reported that 17b-estradiol attenuates saturated fatty acid diet-induced apoptotic liver injury in ovariectomized mice by up-regulating hepatic SMP30 [14] . Thus, the lipid deposition accompanied by increased oxidative and ER stress in Lepr db/db Smp30 Y/2 mice might result from decreased liver SMP30 levels and in turn exacerbate liver damage via decreased Ca 2+ -pumping activity and anti-oxidative effects of SMP30. Further study will be required to reveal the mechanisms of SMP30 suppression in obesity and obesity-related diseases.
A noteworthy finding of this study is that plasma levels of LDLcho, in particular the smaller sized particles of Fr.no. 12 and Fr.no. 13 that correspond to small dense LDL-cho (sdLDL-cho) and the LDL-cho/HDL-cho ratio in 
Smp30
Y/+ mice. These results indicate that the SMP30 deficiency contributes to increases in plasma sdLDL-cho and decreases in HDL-cho regardless of leptin receptor mutation followed by hyperphagia and obesity. In a human study an association between fatty liver and increased sdLDL-cho was reported [26] [27] [28] . Furthermore, we recently reported that in patients with histologically diagnosed NAFLD/NASH, serum sdLDL-cho levels in patients with NAS $5 were significantly higher than those in patients with NAS#2, and sdLDL-cho was significantly and inversely correlated with hepatic SMP30 levels [29] . However, we do not presently have an explanation for the observed increase in sdLDL-cho in Lepr db/db Smp30 Y/2 mice. In humans, TG-rich VLDL (large VLDL1) can be a precursor of sdLDL-cho, i.e., large VLDL1 particles are converted to sdLDL particles by cholesteryl ester transport protein (CETP) and hepatic lipase (HL), the levels of which are commonly increased in type 2 diabetes [30] . Unlike humans, however, mice do not express ) . Recently, we demonstrated that testosterone-deficient mice fed a high-fat diet showed markedly decreased serum TG and TG-VLDL levels and markedly increased serum sdLDL-cho levels, likely due to altered expression of genes involved in hepatic assembly and lipid secretion [32] . Further work will be required to elucidate the molecular mechanism for this increase in sdLDL-cho in SMP30-KO mice.
An additional notable finding of this study was that although Mitochondrial dysfunction is known to cause increases in oxidative stress, and indeed we showed that the levels of TBARS and 4-HNE rose in the livers of Lepr db/db Smp30 Y/2 mice. When SMP30-KO mice are fed a vitamin C-deficient diet they do not thrive and display symptoms of scurvy such as bone fractures and rachitic rosary before dying around three months after beginning the deficient diet. As such, Lepr db/+
Y/2 and Lepr db/db Smp30 Y/2 mice were given vitamin C-supplemented water in this study. Vitamin C is known to play an important role in the structure and function of mitochondria and endoplasmic reticulum [33] . Harrison et al. reported that vitamin E and vitamin C treatment improves fibrosis but not necroinflammation in NASH patients [34] . Therefore, vitamin C supplementation would be one reason that fibrosis was not observed in Lepr db/db Smp30 Y/2 mice in this study.
In this study, Lepr db/+ Smp30 Y/2 mice exhibited no phenotypes for lipid accumulation and mitochondrial damage in the liver as was previously reported [10] . However, in the previous study, mice were fed an autoclaved CRF-1 diet containing ,55 mg of vitamin C per kg and tap water, and thus the liver vitamin C level in Smp30 Y/2 mice was about 6% that of Smp30 Y/+ mice [8] . Although lipid accumulation and mitochondrial damage were observed in livers of Smp30 Y/2 mice at 12 months [10] , it is unclear whether the phenotypes were caused by SMP30 deficiency (loss of unknown function except for vitamin C biosynthesis) and/ or by vitamin C deficiency. Thus, the lack of steatosis in Lepr db/+
Y/2 mice might result from their younger age (24 weeks) or the vitamin C supplementation in the current study.
Although further studies will be required to define the exact molecular mechanism of the altered lipid homeostasis and liver damage caused by decreases in SMP30 levels, our data strongly suggest that SMP30 is closely associated with NAFLD pathogenesis and might be a possible therapeutic target for NAFLD. 
